Skip to main content

Table 1 Changes in myocardial ischemic tolerance and cardioprotection in animal models of DM

From: Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection

Species—model

Duration or age

Ischemic tolerance

Effect on cardioprotection

Ref.

Type 1 DM

 Mouse—STZ

1 week

⇓

⇓ RPostC

[109]

2 week

⇔

⇓ IPostC

[134]

4–5 week

⇔

⇓ IPostC, ⇓ ACE inhibition

[108]

 Rat—STZ

1 week

⇑

⇓ HOPreC

[113]

2 week

⇑

⇔ IPreC

[116]

2 week

⇔

⇓ Opioid

[107]

2 week

⇔

⇓ Opioid

[112]

2 week

⇔

⇓ Opioid

[298]

2 week

⇓

⇓ Sevoflurane

[106]

4 week

⇔

⇓ Erythropoietin

[13]

4 week

⇓

⇓ APN, ⇓ IPostC

[135]

4–5 week

⇓

⇓ IPostC, ⇓ Sevoflurane

[104]

6 week

⇓

⇓ IPreC

[133]

6 week

⇔

⇓ IPreC

[110]

8 week

⇓

⇓ IPostC

[99]

8 week

⇓

⇓ APN, ⇓ IPostC

[135]

8 week

⇓

⇓ IPreC

[116]

8 week

⇓

⇓ Adenosine

[90]

9 week

⇔

⇓ Sevoflurane

[111]

12 week

⇓

⇓ IPostC

[121]

Unreported

⇔

⇓ Opioid

[103]

 Dog—alloxan/STZ

3 week

⇔

⇓ Isoflurane

[101]

3 week

⇔

⇓ IPreC

[130]

 Rabbit—alloxan

5–6 week

⇔

⇓ LPreC

[102]

TYPE 2 DM

 Mouse—HFD

8 week

⇓

⇓APN

[151]

12 week

⇓

⇓β3-AR

[146]

 Mouse—ob/ob

8–10 week old

⇓

⇓IPreC

[142]

 Mouse—db/db

10–12 week old

⇓

⇓IPostC

[145]

12–14 week old

⇔

⇓IPostC

[134]

Unreported

⇔

⇔Infra-red light

[126]

12 week old

Not tested

⇔H2S PreC

[155]

 Rat—STZ/HFD

6 week

⇔

⇔S1P

[87]

 Rat—HFD

4 week

⇔

⇔Erythropoietin

[13]

8 week

⇑

⇓Sevoflurane

[496]

 Rat—ZDF

12 week old

⇔

⇔Glutamate

[154]

16 week old

⇑

⇓IPreC

[91]

 Rat—ZO

10–12 week old

⇓

⇓IPreC, ⇓Diazoxide, ⇓HePreC

[141]

 Rat—GK

12 week old

⇔

⇓PPAR

[150]

 Rat—OLETF

25–30 week old

⇓

⇓Erythropoietin

[132]

 Rat—mtFHH

12–14 week old

⇔

⇓Isoflurane

[149]

  1. HFD high fat diet, ZDF Zucker diabetic fatty, ZO Zucker obese, GK Goto-Kakizaki, OLETF Otsuka Long-Evans-Tokushima fatty, mtFHH T2D crossbreed with mtDNA from fawn hooded hypertensive rats, IPreC ischaemic preconditioning, IPostC ischaemic postconditioning, HOPreC hyperoxic preconditioning, HePreC helium preconditioning, LPreC ischaemic late preconditioning, RPreC remote preconditioning, S1P sphingosine-1-phosphate, APN adiponectin, β 3 -AR β3-adrenergic receptor, w weeks